Efficacy & Safety of FF-31501 in Meniscus Tear Patients

Updated 06/21/2024

Status Active, not recruiting

Clinical Trial Summary

A single-arm, multi-center study to verify that knee joint function at 52 weeks after injection of FF-31501 is better than at screening in patients with meniscus tear who are eligible for meniscectomy .

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Meniscus Injury

Clinical Trial Details

NCT number	NCT05777967
Study type	Interventional
Source	FUJIFILM Toyama Chemical Co., Ltd.
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	January 1, 2023
Completion date	December 31, 2025

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03350204` - Biomechanical Osteoarthritis Outcomes in Meniscectomy Patients	N/A
	Recruiting	`NCT04997538` - Study on Susceptibility Genes of Anterior Cruciate Ligament, Patella Dislocation and Discoid Meniscus
	Completed	`NCT04455516` - Meniscus Repair With Simultaneous ACL Reconstruction: Clinical Outcomes，Failure Rates And Subsequent Processing
	Completed	`NCT06309901` - Facial Distortion Model and Instrument Assisted Soft Tissue Mobilization Techniques
	Active, not recruiting	`NCT03839238` - Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury	Phase 1
	Completed	`NCT01871272` - Knee Arthroscopy Cohort Southern Denmark (KACS)	N/A
	Completed	`NCT03379415` - The Effect of Commercially Available Footwear Interventions in Meniscectomy Patients	N/A
	Recruiting	`NCT04962555` - Clinical Related Study on Surgical Treatment of Knee Joint Meniscus Injury